Effects of CCR5-Δ32, CCR2-641, and SDF-1 3′A alleles on HIV-1 disease progression:: An international meta-analysis of individual-patient data

被引：254

作者：

Ioannidis, JPA ^{[1
]}

Rosenberg, PS ^{[1
]}

Goedert, JJ ^{[1
]}

Ashton, LJ ^{[1
]}

Benfield, TL ^{[1
]}

Buchbinder, SP ^{[1
]}

Coutinho, RA ^{[1
]}

Eugen-Olsen, J ^{[1
]}

Gallart, T ^{[1
]}

Katzenstein, TL ^{[1
]}

Kostrikis, LG ^{[1
]}

Kuipers, H ^{[1
]}

Louie, LG ^{[1
]}

Mallal, SA ^{[1
]}

Margolick, JB ^{[1
]}

Martinez, OP ^{[1
]}

Meyer, L ^{[1
]}

Michael, NL ^{[1
]}

Operskalski, E ^{[1
]}

Pantaleo, G ^{[1
]}

Rizzardi, GP ^{[1
]}

Schuitemaker, H ^{[1
]}

Sheppard, HW ^{[1
]}

Stewart, GJ ^{[1
]}

Theodorou, ID ^{[1
]}

Ullum, H ^{[1
]}

Vicenzi, E ^{[1
]}

Vlahov, D ^{[1
]}

Wilkinson, D ^{[1
]}

Workman, C ^{[1
]}

Zagury, JF ^{[1
]}

O'Brien, TR ^{[1
]}

机构：

[1] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2001年 / 135卷 / 09期

关键词：

D O I：

10.7326/0003-4819-135-9-200111060-00008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Studies relating certain chemokine and chemokine receptor gene alleles with the outcome of HIV-1 infection have yielded inconsistent results. Objective: To examine postulated associations of genetic alleles with HIV-1 disease progression. Design: Meta-analysis of individual-patient data. Setting: 19 prospective cohort studies and case-control studies from the United States, Europe, and Australia. Patients: Patients with HIV-1 infection who were of European or African descent. Measurements: Time to AIDS, death, and death after AIDS and HIV-1 RNA level at study entry or soon after seroconversion. Data were combined with fixed-effects and random-effects models. Results: Both the CCR5-Delta 32 and CCR2-641 alleles were associated with a decreased risk for progression to AIDS (relative hazard among seroconverters, 0.74 and 0.76, respectively; P = 0.01 for both), a decreased risk for death (relative hazard among seroconverters, 0.64 and 0.74; P < 0.05 for both), and lower HIV-1 RNA levels after seroconversion (difference, -0.18 log(10) copies/mL and -0.14 log(10) copies/mL; P < 0.05 for both). Having the CCR5-Delta 32 or CCR2-641 allele had no clear protective effect on the risk for death after development of AIDS. The results were consistent between seroconverters and seroprevalent patients. In contrast SDF-1 YA homozygotes showed no decreased risk for AIDS (relative hazard for seroconverters and seroprevalent patients, 0.99 and 1.03, respectively), death (relative hazard, 0.97 and 1.00), or death after development of AIDS (relative hazard, 0.81 and 0.97; P > 0.5 for all). Conclusions: The CCR5-Delta 32 and CCR2-641 alleles had a strong protective effect on progression of HIV-1 infection, but SDF-1 XA homozygosity carried no such protection.

引用

页码：782 / 795

页数：14

共 47 条

[1] Cancer: What should be done? [J].

Bishop, JM .

SCIENCE, 1997, 278 (5340) :995-995

[2]

Bjorndal A, 1997, J VIROL, V71, P7478

[3] Shorter survival of SDF1-3′Al3′A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type I infection [J].

Brambilla, A ;

Villa, C ;

Rizzardi, G ;

Veglia, F ;

Ghezzi, S ;

Lazzarin, A ;

Cusini, M ;

Muratori, S ;

Santagostino, E ;

Gringeri, A ;

Louie, LG ;

Sheppard, HW ;

Poli, G ;

Michael, NL ;

Pantaleo, G ;

Vicenzi, E .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :311-315

[4]

Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V36, p1S

[5]

COX DR, 1972, J R STAT SOC B, V34, P187

[6] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].

Dean, M ;

Carrington, M ;

Winkler, C ;

Huttley, GA ;

Smith, MW ;

Allikmets, R ;

Goedert, JJ ;

Buchbinder, SP ;

Vittinghoff, E ;

Gomperts, E ;

Donfield, S ;

Vlahov, D ;

Kaslow, R ;

Saah, A ;

Rinaldo, C ;

Detels, R ;

OBrien, SJ .

SCIENCE, 1996, 273 (5283) :1856-1862

[7] Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals [J].

Eugen-Olsen, J ;

Iversen, AKN ;

Benfield, TL ;

Koppelhus, U ;

Garred, P .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 (02) :110-116

[8] Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals [J].

EugenOlsen, J ;

Iversen, AKN ;

Garred, P ;

Koppelhus, U ;

Pedersen, C ;

Benfield, TL ;

Sorensen, AM ;

Katzenstein, T ;

Dickmeiss, E ;

Gerstoft, J ;

Skinhoj, P ;

Svejgaard, A ;

Nielsen, JO ;

Hofmann, B .

AIDS, 1997, 11 (03) :305-310

[9]

Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202

[10] Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes [J].

Gonzalez, E ;

Bamshad, M ;

Sato, N ;

Mummidi, S ;

Dhanda, R ;

Catano, G ;

Cabrera, S ;

McBride, M ;

Cao, XH ;

Merrill, G ;

O'Connell, P ;

Bowden, DW ;

Freedman, BI ;

Anderson, SA ;

Walter, EA ;

Evans, JS ;

Stephan, KT ;

Clark, RA ;

Tyagi, S ;

Ahuja, SS ;

Dolan, MJ ;

Ahuja, SK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12004-12009

← 1 2 3 4 5 →